This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
West Nile Neuroinvasive Disease, West Nile Virus Infection, Encephalitis, Meningitis, Acute Flaccid Paralysis or West Nile Fever
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study will test a drug called MGAWN1 for the treatment of West Nile infections.

Provided treatments

  • Biological: MGAWN1
  • Biological: Placebo - normal saline
Tris trial is registered with FDA with number: NCT00927953. The sponsor of the trial is MacroGenics and it is looking for 13 volunteers for the current phase.
Official trial title:
Phase 2, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MGAWN1 in Subjects With Laboratory-documented West Nile Fever or Suspected Central Nervous System Infection Due to West Nile Virus